Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators

被引：18

作者：

Greig, Iain R. ^{[1
]}

Baillie, Gemma L. ^{[1
,2
,3
]}

Abdelrahman, Mostafa ^{[4
,5
]}

Trembleau, Laurent ^{[4
]}

Ross, Ruth A. ^{[1
,2
,3
]}

机构：

[1] Univ Aberdeen, Inst Med Sci, Kosterlitz Ctr Therapeut, Aberdeen AB25 2ZD, Scotland

[2] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada

[3] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5S 1A8, Canada

[4] Univ Aberdeen, Sch Nat & Comp Sci, Lab Supramol Chem, Aberdeen AB24 3UE, Scotland

[5] Al Azhar Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Assiut 71524, Egypt

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2016年 / 26卷 / 18期

基金：

英国生物技术与生命科学研究理事会;

关键词：

Cannabinoid; Negative allosteric modulator; CB1; NAM; Indole sulfonamide; CB1; RECEPTORS; INDOLE-2-CARBOXAMIDES; FUNCTIONALITIES; ANTAGONIST; SYSTEM;

D O I：

10.1016/j.bmcl.2016.08.018

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Existing CB1 negative allosteric modulators (NAMs) fall into a limited range of structural classes. In spite of the theoretical potential of CB1 NAMs, published in vivo studies have generally not been able to demonstrate the expected therapeutically-relevant CB1-mediated effects. Thus, a greater range of molecular tools are required to allow definitive elucidation of the effects of CB1 allosteric modulation. In this study, we show a novel series of indole sulfonamides. Compounds 5e and 6c (ABD1075) had potencies of 4 and 3 nM respectively, and showed good oral exposure and CNS penetration, making them highly versatile tools for investigating the therapeutic potential of allosteric modulation of the cannabinoid system. Crown Copyright (C) 2016 Published by Elsevier Ltd. All rights reserved.

引用

页码：4403 / 4407

页数：5

共 50 条

[21] Recent Advances in the Design and Development of Novel Negative Allosteric Modulators of mGlu5 [J].

Emmitte, Kyle A. .

ACS CHEMICAL NEUROSCIENCE, 2011, 2 (08) :411-432

[22] 6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulators [J].

Weiss, Jesse M. ;

Jimenez, Hermogenes N. ;

Li, Guiying ;

April, Myriam ;

Uberti, Michelle A. ;

Bacolod, Maria D. ;

Brodbeck, Robb M. ;

Doller, Dario .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (16) :4891-4899

[23] Structure optimization of Cmpd-15 as negative allosteric modulators for the β2-adrenergic receptor [J].

Guo, Xue ;

Luo, Zhijie ;

Qi, Ying ;

Hei, Xiaoyuan ;

Zhang, Xin ;

Cao, Xuli ;

Qian, Mingcheng ;

Zhao, Shuai ;

Hou, Yanan ;

Chen, Xin .

BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 108

[24] Discovery and characterization of AZD9272 and AZD6538-Two novel mGluR5 negative allosteric modulators selected for clinical development [J].

Raboisson, Patrick ;

Breitholtz-Emanuelsson, Anna ;

Dahlloef, Henrik ;

Edwards, Louise ;

Heaton, William L. ;

Isaac, Methvin ;

Jarvie, Keith ;

Kers, Annika ;

Minidis, Alexander B. E. ;

Nordmark, Anna ;

Sheehan, Susan M. ;

Slassi, Abdelmalik ;

Stroem, Peter ;

Terelius, Ylva ;

Wensbo, David ;

Wilson, Julie M. ;

Xin, Tao ;

McLeod, Donald A. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (22) :6974-6979

[25] The future of type 1 cannabinoid receptor allosteric ligands [J].

Alaverdashvili, Mariam ;

Laprairie, Robert B. .

DRUG METABOLISM REVIEWS, 2018, 50 (01) :14-25

[26] Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution [J].

Nguyen, Thuy ;

German, Nadezhda ;

Decker, Ann M. ;

Langston, Tiffany L. ;

Gamage, Thomas F. ;

Farquhar, Charlotte E. ;

Li, Jun-Xu ;

Wiley, Jenny L. ;

Thomas, Brian F. ;

Zhang, Yanan .

JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (17) :7410-7424

[27] Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor [J].

Shivshankar, Samay ;

Nimely, Josephine ;

Puhl III, Henry ;

Iyer, Malliga R. .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)

[28] Discovery of indole alkaloids with cannabinoid CB1 receptor antagonistic activity [J].

Kitajima, Mariko ;

Iwai, Masumi ;

Kikura-Hanajiri, Ruri ;

Goda, Yukihiro ;

Iida, Mitsuru ;

Yabushita, Hisatoshi ;

Takayama, Hiromitsu .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) :1962-1964

[29] mGlu5 negative allosteric modulators: a patent review (2013-2016) [J].

Emmitte, Kyle A. .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (06) :691-706

[30] Structural Optimization of the Diarylurea PSNCBAM-1, an Allosteric Modulator of Cannabinoid Receptor 1 [J].

Dopart, Rachel ;

Immadi, Sri Sujana ;

Lu, Dai ;

Kendall, Debra A. .

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 92

← 1 2 3 4 5 →